{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:15:39Z","timestamp":1794777339359,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473415"],"award-info":[{"award-number":["82473415"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273301"],"award-info":[{"award-number":["82273301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173160"],"award-info":[{"award-number":["82173160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018541","name":"Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars","doi-asserted-by":"crossref","award":["BK20240018"],"award-info":[{"award-number":["BK20240018"]}],"id":[{"id":"10.13039\/501100018541","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nanjing Health Technology Development Project Foundation for Distinguished Young Scholars","award":["JQX23001"],"award-info":[{"award-number":["JQX23001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The pathogenesis of bladder cancer (BCa) is driven in part by aberrant epigenetic regulation, most notably the dysregulated expression of histone deacetylases (HDACs). As a class I HDAC, HDAC2 is often overexpressed in cancers and promotes malignancy through diverse mechanisms. Given its broad oncogenic role, an in-depth investigation of its specific functions in epigenetic and post-translational regulation within BCa holds significant promise for developing novel precision therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vitro<\/jats:italic>\n                      functional assays, including CCK-8, colony formation, transwell and apoptotic assays, as well as\n                      <jats:italic>in vivo<\/jats:italic>\n                      assays in a nude mouse subcutaneous tumor model, were performed to assess the oncogenic and drug-resistant effects of HDAC2. RNA-seq and ATAC-seq were employed to analyze the epigenetic regulatory mechanisms of HDAC2. Combined proteome, lactylome and acetylome analysis of control and HDAC2-overexpressing BCa cells were conducted to map the global profiling of protein lysine acetylation (Kac) and lactylation (Kla).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vitro<\/jats:italic>\n                      and\n                      <jats:italic>in vivo<\/jats:italic>\n                      experiments confirmed that HDAC2 overexpression significantly promoted proliferation, metastasis and chemoresistance of BCa. Integrated RNA-seq and ATAC-seq analysis revealed that HDAC2 overexpression led to significant epigenetic alternations, and knockdown of its downstream GRIK2 significantly reversed the oncogenic effects of HDAC2. We screened class I HDACs for their impact on Kac and Kla in BCa cells and found that HDAC2 most significantly reduced global Kla levels. Subsequent proteomic analysis of HDAC2-overexpressing cells identified 528 differentially regulated Kla proteins (encompassing 683 sites) and 1,129 differentially regulated Kac proteins (encompassing 1,458 sites). Notably, DHX15 in the splicesome pathway emerged as the most prominent HDAC2-regulated lactylated protein in the absence of concurrent Kac alterations. Moreover, HDAC2 promoted BCa malignancy through the downregulation of DHX15 Kla and the subsequent modulation of RPL9 splicing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Collectively, these findings suggest the pivotal role of HDAC2 in epigenetic modulation and lysine lactylation, and underscore HDAC2 as a promising therapeutic target in BCa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03610-5","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:33:52Z","timestamp":1765967632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["HDAC2 as a therapeutic target in bladder cancer: insights into the altered epigenetic regulation and lysine lactylation"],"prefix":"10.1186","volume":"45","author":[{"given":"Guanghui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganlin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"3","key":"3610_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3610_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234\u201341.","journal-title":"Eur Urol"},{"issue":"1","key":"3610_CR3","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"3610_CR4","first-page":"1980","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, et al. Bladder Cancer: Rev Jama. 2020;324(19):1980\u201391.","journal-title":"Bladder Cancer: Rev Jama"},{"key":"3610_CR5","doi-asserted-by":"publisher","first-page":"100938","DOI":"10.1016\/j.drup.2023.100938","volume":"68","author":"F Li","year":"2023","unstructured":"Li F, et al. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms. Drug Resist Updat. 2023;68:100938.","journal-title":"Drug Resist Updat"},{"issue":"5","key":"3610_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"key":"3610_CR7","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059.","journal-title":"Drug Resist Updat"},{"issue":"14","key":"3610_CR8","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.7150\/ijbs.45640","volume":"16","author":"M Shahid","year":"2020","unstructured":"Shahid M, et al. S-Palmitoylation as a functional regulator of proteins associated with cisplatin resistance in bladder cancer. Int J Biol Sci. 2020;16(14):2490\u2013505.","journal-title":"Int J Biol Sci"},{"issue":"18","key":"3610_CR9","doi-asserted-by":"publisher","first-page":"e2501734","DOI":"10.1002\/advs.202501734","volume":"12","author":"X Zhang","year":"2025","unstructured":"Zhang X, et al. SUMOylation of SETD8 promotes tumor growth by methylating and stabilizing MYC in bladder cancer. Adv Sci (Weinh). 2025;12(18):e2501734.","journal-title":"Adv Sci (Weinh)"},{"issue":"37","key":"3610_CR10","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.2174\/0929867324666170207142740","volume":"24","author":"M Pinkerneil","year":"2017","unstructured":"Pinkerneil M, et al. HDACs and HDAC inhibitors in urothelial Carcinoma - Perspectives for an antineoplastic treatment. Curr Med Chem. 2017;24(37):4151\u201365.","journal-title":"Curr Med Chem"},{"issue":"8","key":"3610_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1464-410X.2009.08795.x","volume":"105","author":"A Ozawa","year":"2010","unstructured":"Ozawa A, et al. Inhibition of bladder tumour growth by histone deacetylase inhibitor. BJU Int. 2010;105(8):1181\u20136.","journal-title":"BJU Int"},{"issue":"2","key":"3610_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1158\/1535-7163.MCT-15-0618","volume":"15","author":"M Pinkerneil","year":"2016","unstructured":"Pinkerneil M, et al. Inhibition of class I histone deacetylases 1 and 2 promotes urothelial carcinoma cell death by various mechanisms. Mol Cancer Ther. 2016;15(2):299\u2013312.","journal-title":"Mol Cancer Ther"},{"key":"3610_CR13","doi-asserted-by":"crossref","unstructured":"Giannopoulou AF, et al. Revisiting histone deacetylases in human tumorigenesis: the paradigm of urothelial bladder cancer. Int J Mol Sci. 2019;20(6):1291.","DOI":"10.3390\/ijms20061291"},{"issue":"11","key":"3610_CR14","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1182\/blood-2012-08-450916","volume":"121","author":"MR Heideman","year":"2013","unstructured":"Heideman MR, et al. Dosage-dependent tumor suppression by histone deacetylases 1 and 2 through regulation of c-Myc collaborating genes and p53 function. Blood. 2013;121(11):2038\u201350.","journal-title":"Blood"},{"issue":"6","key":"3610_CR15","doi-asserted-by":"publisher","first-page":"e1692","DOI":"10.1002\/ctm2.1692","volume":"14","author":"X Guan","year":"2024","unstructured":"Guan X, et al. Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3\/GSDMD-mediated pyroptosis in colorectal cancer. Clin Transl Med. 2024;14(6):e1692.","journal-title":"Clin Transl Med"},{"key":"3610_CR16","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1017\/erm.2022.42","volume":"25","author":"X Lv","year":"2023","unstructured":"Lv X, Lv Y, Dai X. Lactate, histone lactylation and cancer hallmarks. Expert Rev Mol Med. 2023;25:e7.","journal-title":"Expert Rev Mol Med"},{"issue":"2","key":"3610_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell. 2024;187(2):294\u2013e31121.","journal-title":"Cell"},{"issue":"8021","key":"3610_CR18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen H, et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature. 2024;631(8021):663\u20139.","journal-title":"Nature"},{"issue":"1","key":"3610_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","volume":"5","author":"Z Yang","year":"2023","unstructured":"Yang Z, et al. Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma. Nat Metab. 2023;5(1):61\u201379.","journal-title":"Nat Metab"},{"key":"3610_CR20","doi-asserted-by":"crossref","unstructured":"Sun K, et al. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025;135(7):e187024.","DOI":"10.1172\/JCI187024"},{"issue":"38","key":"3610_CR21","doi-asserted-by":"publisher","first-page":"e2405975","DOI":"10.1002\/advs.202405975","volume":"11","author":"F Feng","year":"2024","unstructured":"Feng F, et al. Lactylome analysis unveils Lactylation-Dependent mechanisms of stemness remodeling in the liver cancer stem cells. Adv Sci (Weinh). 2024;11(38):e2405975.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"3610_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cmet.2024.11.005","volume":"37","author":"R Liu","year":"2025","unstructured":"Liu R, et al. Nuclear GTPSCS functions as a lactyl-CoA synthetase to promote histone lactylation and gliomagenesis. Cell Metab. 2025;37(2):377\u2013e3949.","journal-title":"Cell Metab"},{"issue":"8","key":"3610_CR23","doi-asserted-by":"publisher","first-page":"e2314128121","DOI":"10.1073\/pnas.2314128121","volume":"121","author":"B Xie","year":"2024","unstructured":"Xie B, et al. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc Natl Acad Sci U S A. 2024;121(8):e2314128121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3610_CR24","doi-asserted-by":"publisher","first-page":"eabi6696","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022;8(3):eabi6696.","journal-title":"Sci Adv"},{"issue":"10","key":"3610_CR25","doi-asserted-by":"publisher","first-page":"110911","DOI":"10.1016\/j.isci.2024.110911","volume":"27","author":"R Du","year":"2024","unstructured":"Du R, et al. Sirtuin 1\/sirtuin 3 are robust lysine delactylases and Sirtuin 1-mediated delactylation regulates Glycolysis. iScience. 2024;27(10):110911.","journal-title":"iScience"},{"issue":"10","key":"3610_CR26","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1093\/nar\/gkae183","volume":"52","author":"X Hu","year":"2024","unstructured":"Hu X, et al. Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader. Nucleic Acids Res. 2024;52(10):5529\u201348.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3610_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00262-021-03025-z","volume":"71","author":"H Miyata","year":"2022","unstructured":"Miyata H, et al. GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy. Cancer Immunol Immunother. 2022;71(4):795\u2013806.","journal-title":"Cancer Immunol Immunother"},{"key":"3610_CR28","doi-asserted-by":"crossref","unstructured":"Zheng X, et al. G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC-I via PI3K\/Akt Activation in Bladder Cancer. Adv Sci (Weinh). 2024;11(7):e2305922.","DOI":"10.1002\/advs.202305922"},{"key":"3610_CR29","doi-asserted-by":"crossref","unstructured":"Yu J, et al. RBPMS inhibits bladder cancer metastasis by downregulating MYC pathway through alternative splicing of ANKRD10. Commun Biol. 2025;8(1):367.","DOI":"10.1038\/s42003-025-07842-1"},{"issue":"49","key":"3610_CR30","doi-asserted-by":"publisher","first-page":"e2216712119","DOI":"10.1073\/pnas.2216712119","volume":"119","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. DHX15 is involved in SUGP1-mediated RNA missplicing by mutant SF3B1 in cancer. Proc Natl Acad Sci U S A. 2022;119(49):e2216712119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3610_CR31","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1158\/0008-5472.CAN-13-2109","volume":"74","author":"JH Noh","year":"2014","unstructured":"Noh JH, et al. HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT. Cancer Res. 2014;74(6):1728\u201338.","journal-title":"Cancer Res"},{"issue":"5","key":"3610_CR32","first-page":"1213","volume":"7","author":"W Shan","year":"2017","unstructured":"Shan W, et al. HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer. Am J Cancer Res. 2017;7(5):1213\u201326.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"3610_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41418-024-01271-z","volume":"31","author":"H Chen","year":"2024","unstructured":"Chen H, et al. Hypoxia-activated XBP1s recruits HDAC2-EZH2 to engage epigenetic suppression of \u2206Np63\u03b1 expression and promote breast cancer metastasis independent of HIF1\u03b1. Cell Death Differ. 2024;31(4):447\u201359.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3610_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-024-02013-y","volume":"23","author":"D Wen","year":"2024","unstructured":"Wen D, et al. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2. Mol Cancer. 2024;23(1):116.","journal-title":"Mol Cancer"},{"issue":"8","key":"3610_CR35","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41419-021-04047-2","volume":"12","author":"P Xu","year":"2021","unstructured":"Xu P, et al. Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression. Cell Death Dis. 2021;12(8):779.","journal-title":"Cell Death Dis"},{"key":"3610_CR36","doi-asserted-by":"crossref","unstructured":"Hoffmann MJ, et al. Downregulation of cell cycle and checkpoint genes by class I HDAC inhibitors limits synergism with G2\/M checkpoint inhibitor MK-1775 in bladder cancer cells. Genes (Basel). 2021;12(2):260.","DOI":"10.3390\/genes12020260"},{"issue":"9","key":"3610_CR37","doi-asserted-by":"publisher","first-page":"e18342","DOI":"10.1111\/jcmm.18342","volume":"28","author":"S Meneceur","year":"2024","unstructured":"Meneceur S, et al. New synergistic combination therapy approaches with HDAC inhibitor quisinostat, cisplatin or PARP inhibitor Talazoparib for urothelial carcinoma. J Cell Mol Med. 2024;28(9):e18342.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"3610_CR38","doi-asserted-by":"publisher","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6(4):a018713.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"3610_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molcel.2008.07.002","volume":"31","author":"XJ Yang","year":"2008","unstructured":"Yang XJ, Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell. 2008;31(4):449\u201361.","journal-title":"Mol Cell"},{"issue":"3","key":"3610_CR40","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/gutjnl-2011-300060","volume":"61","author":"A Aghdassi","year":"2012","unstructured":"Aghdassi A, et al. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer. Gut. 2012;61(3):439\u201348.","journal-title":"Gut"},{"issue":"1","key":"3610_CR41","doi-asserted-by":"crossref","first-page":"e3711","DOI":"10.1053\/j.gastro.2009.04.004","volume":"137","author":"J von Burstin","year":"2009","unstructured":"von Burstin J, et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL\/HDAC1\/HDAC2 repressor complex. Gastroenterology. 2009;137(1):e3711\u20135. 361\u2009\u2013\u200971.","journal-title":"Gastroenterology"},{"issue":"1","key":"3610_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gr.278050.123","volume":"34","author":"RDW Kelly","year":"2024","unstructured":"Kelly RDW, et al. Histone deacetylases maintain expression of the pluripotent gene network via recruitment of RNA polymerase II to coding and noncoding loci. Genome Res. 2024;34(1):34\u201346.","journal-title":"Genome Res"},{"issue":"1","key":"3610_CR43","doi-asserted-by":"publisher","first-page":"5209","DOI":"10.1038\/s41467-024-49573-7","volume":"15","author":"L Sun","year":"2024","unstructured":"Sun L, et al. Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors. Nat Commun. 2024;15(1):5209.","journal-title":"Nat Commun"},{"issue":"9","key":"3610_CR44","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41556-020-0562-4","volume":"22","author":"Y Gao","year":"2020","unstructured":"Gao Y, et al. Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy. Nat Cell Biol. 2020;22(9):1064\u201375.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3610_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41421-023-00573-9","volume":"9","author":"J Li","year":"2023","unstructured":"Li J, et al. HDAC1\/2\/3 are major histone desuccinylases critical for promoter desuccinylation. Cell Discov. 2023;9(1):85.","journal-title":"Cell Discov"},{"issue":"1","key":"3610_CR46","doi-asserted-by":"publisher","first-page":"14690","DOI":"10.1038\/s41598-018-32927-9","volume":"8","author":"RDW Kelly","year":"2018","unstructured":"Kelly RDW, et al. Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo. Sci Rep. 2018;8(1):14690.","journal-title":"Sci Rep"},{"issue":"14","key":"3610_CR47","doi-asserted-by":"publisher","first-page":"e2413121","DOI":"10.1002\/advs.202413121","volume":"12","author":"X He","year":"2025","unstructured":"He X, et al. HDAC2-Mediated METTL3 delactylation promotes DNA damage repair and chemotherapy resistance in Triple-Negative breast cancer. Adv Sci (Weinh). 2025;12(14):e2413121.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"3610_CR48","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","volume":"42","author":"H Li","year":"2024","unstructured":"Li H, et al. Lactylation in cancer: current Understanding and challenges. Cancer Cell. 2024;42(11):1803\u20137.","journal-title":"Cancer Cell"},{"issue":"1","key":"3610_CR49","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10(1):38.","journal-title":"Signal Transduct Target Ther"},{"key":"3610_CR50","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.drup.2025.101248","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, et al. Lactylation in cancer progression and drug resistance. Drug Resist Updat. 2025;81:101248.","journal-title":"Drug Resist Updat"},{"issue":"4","key":"3610_CR51","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jhep.2024.04.010","volume":"81","author":"L Yang","year":"2024","unstructured":"Yang L, et al. Nucleolin lactylation contributes to intrahepatic cholangiocarcinoma pathogenesis via RNA splicing regulation of MADD. J Hepatol. 2024;81(4):651\u201366.","journal-title":"J Hepatol"},{"issue":"10","key":"3610_CR52","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187(10):2375\u2013e239233.","journal-title":"Cell"},{"key":"3610_CR53","doi-asserted-by":"crossref","unstructured":"Ju J, et al. The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer. J Clin Invest. 2024;134(10):e174587.","DOI":"10.1172\/JCI174587"},{"issue":"8036","key":"3610_CR54","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","volume":"634","author":"H Li","year":"2024","unstructured":"Li H, et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature. 2024;634(8036):1229\u201337.","journal-title":"Nature"},{"issue":"5","key":"3610_CR55","doi-asserted-by":"publisher","first-page":"e56052","DOI":"10.15252\/embr.202256052","volume":"24","author":"J Jin","year":"2023","unstructured":"Jin J, et al. SIRT3-dependent delactylation of Cyclin E2 prevents hepatocellular carcinoma growth. EMBO Rep. 2023;24(5):e56052.","journal-title":"EMBO Rep"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03610-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:02:27Z","timestamp":1768996947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03610-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3610"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03610-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving animals were carried out in compliance with the guidelines of the Institutional Animal Care and Use Committee of Nanjing Drum Tower Hospital, and followed ethical guidelines protocols established by Nanjing University Medical School.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}